Wegovy acid burps: what's causing them and what actually helps

Picture the moment: post-injection, mid-afternoon, and the burping starts

It usually begins an hour or two after your weekly semaglutide injection. A fullness that sits oddly high, then a string of loud, sour burps that surprise you — and anyone nearby. Some people describe a faintly sulphurous taste; others just notice relentless belching that makes conversation awkward. This is not a sign that something has gone badly wrong. It is, frustratingly, a predictable consequence of what Wegovy is actually doing inside your digestive system.

Semaglutide is a GLP-1 receptor agonist, which means it mimics a gut hormone that tells the stomach to slow down. That slowing is part of why you feel full sooner and eat less. But a stomach that empties slowly is also a stomach where gas, food and acid sit longer than usual, building pressure. That pressure has to go somewhere, and burping is the most common release valve. The full side-effect picture for Wegovy runs wider than this, but upper GI symptoms (nausea, reflux, indigestion, burping) form the dominant cluster for most people early in treatment.

Acid burps specifically involve gastric acid being carried upward alongside the gas, which produces the sour or bitter taste. People who already had mild reflux before starting Wegovy often find it worsens temporarily. The NHS semaglutide medicines page lists burping, indigestion and acid reflux among the recognised common side effects of the medicine.

Why dose increases tend to bring the worst of it

If you felt fine at your starting dose and the burping arrived when you stepped up, that pattern makes complete sense. The gastric-emptying effect of semaglutide is dose-dependent: the higher the dose, the more pronounced the slowdown, and the greater the potential for gas and acid to accumulate. Most people find the first week at a new dose is the roughest, with symptoms easing as the body recalibrates.

The timing of your injection can also play a role. Some people find that injecting in the evening means the peak effect on gastric motility coincides with sleep, when lying flat makes reflux more likely. Others do better injecting in the morning. There is no one-size answer, it's worth tracking what you notice and mentioning it at your next clinical review. Dose timing is a conversation for your prescriber, not something to adjust unilaterally, and your patient information leaflet covers the basics of injection timing.

If the burping is making you dread each weekly dose, that is worth flagging. A prescriber can assess whether a slower titration pace or a different injection day might help, or whether what you're experiencing goes beyond typical adjustment. Staying at a lower dose longer is a recognised clinical option; it is not a failure. You can find practical detail on this in our guidance on managing Wegovy burps.

What you eat makes a bigger difference than most people expect

When gastric emptying is slowed, what you eat has an outsized effect on upper GI symptoms. High-fat meals take the longest to leave the stomach and are the most reliable trigger for reflux and burping in people on semaglutide. Greasy takeaways, creamy sauces, and large portions eaten quickly are the usual culprits. Carbonated drinks add gas on top of gas. Coffee, alcohol and citrus can relax the valve between the oesophagus and stomach, making acid escape upward more easily.

Practical shifts that many people find useful: smaller meals, eaten slowly, with a gap of at least two hours before lying down. Sitting upright after eating. Swapping fried food for grilled or baked. Reducing fizzy drinks. These are not complicated changes, but they tend to make a real difference when the stomach is already working on reduced motility. The connection between Wegovy and acid reflux goes into more detail on the mechanism and the dietary angle specifically.

A note on cost context: if you are weighing up private treatment and wondering whether the side-effect burden is worth it, the Wegovy cost breakdown is a reasonable place to understand what is typically included in a properly structured prescription service versus a bare-bones one, aftercare support during dose increases is where the difference is often felt most.

When burping becomes a warning sign, not just an inconvenience

Burping and mild reflux after each injection are common, manageable and usually self-limiting. But there are symptoms that sit in a different category entirely, and it is worth being clear about them.

The MHRA has highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 medicines. The warning sign is severe abdominal pain (typically in the upper abdomen) that does not pass, and may radiate through to the back, sometimes alongside vomiting. That is not a Wegovy burp. That requires urgent medical attention. Stop the medicine and contact a doctor or call 111 promptly if you experience that pattern of pain.

Gallbladder problems are also recognised with semaglutide. Symptoms include upper right abdominal pain, nausea and sometimes fever. Again, these need clinical assessment rather than dietary adjustment. The NHS semaglutide page covers these symptoms, and side effects including serious ones can be reported through the MHRA Yellow Card scheme.

For the specific picture of sulphurous-tasting burps (a question our prescribers hear regularly) there is more at egg burps and Wegovy, which addresses the distinct hydrogen-sulphide mechanism that can make some people's burps smell worse than others. More broadly, understanding whether Wegovy causes acid reflux in a clinical sense may help you make sense of your own symptoms.

If you are not yet on treatment and want a clinical assessment from a GPhC-registered prescriber who can discuss your full symptom picture (including how to manage side effects at each dose stage) you can speak to our prescribers as a starting point.